How Late-Stage Intervention And Regional Expansion Transformed Patient Enrollment In Just 3 Months

Palleos successfully executed a challenging three-arm, randomized, placebo-controlled Phase 3 study in Ulcerative Colitis. Despite strict inclusion criteria and limited patient pool, the Palleos team overcame recruitment challenges by expanding to new regions (Lebanon, Jordan), implementing referral programs, and optimizing site engagement. Palleos innovative approach delivered results in this complex indication.